Literature DB >> 741213

Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis.

J Eldh, B Boeryd, L E Peterson.   

Abstract

In a retrospective study of 324 cutaneous malignant melanomas in stage I, treated during the years 1959-74, the influence of different morphological and clinical factors on the prognosis was investigated. 223 patients with melanoma in levels II-V, observed for more than five years, were subjected to a multivariate analysis. 180/223 were in levels III-V. The age of the patient, the location of the tumour, its diameter, thickness, infiltration level, presence of ulceration and mitotic activity were shown to be of significant importance for the five-year survival of the 223 patients. Analysis limited to levels III-V disclosed that the diameter and the thickness of the tumour but not the infiltration level significantly influenced the prognosis. However, the sex of the patient, the histogenetic type of the tumour, the cross-sectional profile, vascular invasion and degree of lymphocytic infiltration did not correlate with survival.

Entities:  

Mesh:

Year:  1978        PMID: 741213     DOI: 10.3109/02844317809013000

Source DB:  PubMed          Journal:  Scand J Plast Reconstr Surg        ISSN: 0036-5556


  22 in total

1.  Malignant melanoma and pregnancy ten questions.

Authors:  R O Dillman; L A Vandermolen; N M Barth; K J Bransford
Journal:  West J Med       Date:  1996-02

2.  Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat.

Authors:  C L Day; T J Harrist; F Gorstein; A J Sober; R A Lew; R J Friedman; B S Pasternack; A W Kopf; T B Fitzpatrick; M C Mihm
Journal:  Ann Surg       Date:  1981-07       Impact factor: 12.969

3.  Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.

Authors:  J W Kelly; R W Sagebiel; S Clyman; M S Blois
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

4.  Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.

Authors:  R W Griffiths; J C Briggs
Journal:  Ann R Coll Surg Engl       Date:  1985-03       Impact factor: 1.891

5.  The extent of primary melanoma excision. A re-evaluation--how wide is wide?

Authors:  D R Aitken; K Clausen; J P Klein; A G James
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

6.  Site distribution of malignant melanoma.

Authors:  J M Elwood; R P Gallagher
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

7.  Prognostic value of tumour thickness in cutaneous malignant melanoma.

Authors:  I Jeffrey; P Royston; C Sowter; G Slavin; A Price; A Pomerance; S Goolamali; D Pinto
Journal:  J Clin Pathol       Date:  1983-01       Impact factor: 3.411

8.  Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.

Authors:  C Callery; A J Cochran; D J Roe; W Rees; S D Nathanson; J K Benedetti; R M Elashoff; D L Morton
Journal:  Ann Surg       Date:  1982-07       Impact factor: 12.969

9.  Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases.

Authors:  K Søndergaard
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

10.  Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions.

Authors:  C L Day; M C Mihm; A J Sober; M N Harris; A W Kopf; T B Fitzpatrick; R A Lew; T J Harrist; F M Golomb; A Postel; P Hennessey; S L Gumport; J W Raker; R A Malt; A B Cosimi; W C Wood; D F Roses; F Gorstein; D Rigel; R J Friedman; M M Mintzis
Journal:  Ann Surg       Date:  1982-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.